Can rare lymphocytes combat rheumatoid arthritis?
(PHYSorg.com Medicine & Health)

Immunologists at Friedrich-Alexander-Universität Erlangen-Nürnberg have demonstrated that ILC2, a group of rare lymphoid cells, plays a key role in the development of inflammatory arthritis. ILCs have several functional similarities to T-cells and are important agents of the congenital immune system. The FAU researchers` findings could form the basis for new approaches for treating rheumatoid arthritis. The findings have now been published in Cell Reports.